From: Clinical characteristics of dry eye patients with thyroid disorders: a cross-sectional study
With thyroid disorders (n = 47, 47.5%) | With euthyroidism (n = 52, 52.5%) | P value | |
---|---|---|---|
Age (years old) | 43.68 ± 13.35 | 46 ± 13.38 | 0.391 |
Gender (male, %) | 9 (19.1%) | 11 (21.2%) | 0.804 |
With hyperlipemia (n, %) | 1 (2.1%) | 4 (7.7%) | 0.207 |
With autoimmune diseases (n, %) | 22 (46.8%) | 16 (30.8%) | 0.101 |
TMH (mm) | 0.19(0.16, 0.23) | 0.22 (0.18, 0.25) | 0.192 |
NIBUT-first (s) | 4.59 (3.25, 6.12) | 7.33 (5.47, 9.13) | < 0.001* |
NIBUT-avg (s) | 8.13 ± 4.03 | 9.78 ± 3.89 | 0.042* |
S1T (mm/5 min) | 4.00 (1.25, 5.75) | 5.00 (2.00, 8.00) | 0.154 |
CFS (0,15) | 9 (7,11) | 9 (8,11) | 0.241 |
MG dropout ratio (%) | 32.99% (21.08%, 55.39%) | 17.2% (11.2%, 27.1%) | 0.001* |
TSH level (mIU/L) | 1.67(1.12, 2.37) | 1.67 (1.23, 2.11) | 0.664 |
T3 level (nmol/L) | 1.39 (1.23, 1.49) | 1.38 (1.28, 1.49) | 0.731 |
T4 level (nmol/L) | 97.58 ± 17.94 | 98.33 ± 15.47 | 0.824 |
FT3 level (pmol/L) | 4.16 (3.85,4.40) | 4.20 (3.95, 4.39) | 0.814 |
FT4 level (pmol/L) | 12.93 ± 1.95 | 12.90 ± 1.20 | 0.928 |
Anti-TPO level (IU/ml) | 8.65 (5.63, 20.27) | 0.99 (0.54, 2.45) | < 0.001* |
Anti-Tg level (IU/ml) | 1.94 (0.89,26.15) | 0.82 (0.52, 1.18) | < 0.001* |